{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:34:02Z","timestamp":1795034042209,"version":"4.10.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpcardiol.2022.101199","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T20:50:59Z","timestamp":1649451059000},"page":"101199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-3520","authenticated-orcid":false,"given":"Abdul Mannan Khan","family":"Minhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-7288","authenticated-orcid":false,"given":"Huzefa M.","family":"Bhopalwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakeya","family":"Dewaswala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam M.","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izza","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101199_bib0001","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1177\/0300060518782780","article-title":"Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance","volume":"46","author":"Zhang","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0002","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0004","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/oby.21901","article-title":"Is fatty liver a risk marker for heart failure?","volume":"25","author":"VanWagner","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"suppl 1","key":"10.1016\/j.cpcardiol.2022.101199_bib0006","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0008","unstructured":"Overview of the national (Nationwide) inpatient sample (NIS) 2020 Available from: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp. Accessed date Oct 12 2021."},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0009","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjmed.2021.05.022","article-title":"Patient characteristics and outcomes of type 2 myocardial infarction during heart failure hospitalizations in the United States","volume":"134","author":"Nazir","year":"2021","journal-title":"Am J Med."},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction","volume":"272","author":"Chung","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0012","first-page":"20","article-title":"Association between non- alcoholic fatty liver disease and left ventricular diastolic dysfunction in patients of type 2 diabetes","volume":"67","author":"Saluja","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc11-1820","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"35","author":"Bonapace","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0014","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population","volume":"100","author":"Kim","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0016","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.hfc.2014.04.008","article-title":"Phenotypic spectrum of heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2016.01.013","article-title":"Biomarkers for heart failure: an update for practitioners of internal medicine","volume":"129","author":"Wettersten","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2015.10.028","article-title":"Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis","volume":"1862","author":"Coombes","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc11-1820","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"35","author":"Bonapace","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.21983","article-title":"Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver","volume":"47","author":"Perseghin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0023","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2010.02.049","article-title":"Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes","volume":"56","author":"Rijzewijk","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0024","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF03345421","article-title":"Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals","volume":"35","author":"Mantovani","year":"2012","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0027","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","article-title":"Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease","volume":"58","author":"Hallsworth","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0028","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007308","article-title":"Extracardiac abnormalities of preload reserve: mechanisms underlying exercise limitation in heart failure with preserved ejection fraction, autonomic dysfunction, and liver disease","volume":"14","author":"Fudim","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0031","first-page":"457","article-title":"Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease","volume":"17","author":"Fotbolcu","year":"2010","journal-title":"Cardiol J"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0032","first-page":"1118","article-title":"Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents","volume":"29","author":"Alp","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0033","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.amjcard.2013.03.056","article-title":"Left ventricular function by echocardiography, tissue doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease","volume":"112","author":"Sert","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26610","article-title":"Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease","volume":"59","author":"Pacifico","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0037","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0038","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardfail.2019.01.020","article-title":"Relationship of liver stiffness with congestion in patients presenting with acute decompensated heart failure","volume":"25","author":"Soloveva","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0039","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ejhf.532","article-title":"Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101199_bib0040","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/ehf2.12477","article-title":"Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial","volume":"6","author":"Biegus","year":"2019","journal-title":"ESC Heart Fail"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:35:12Z","timestamp":1758940512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0146280622000962"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101199","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101199"}}